Literature DB >> 8132745

Supravalvular aortic stenosis associated with a deletion disrupting the elastin gene.

A K Ewart1, W Jin, D Atkinson, C A Morris, M T Keating.   

Abstract

Supravalvular aortic stenosis (SVAS) is an inherited vascular disease that can cause heart failure and death. SVAS can be inherited as an autosomal dominant trait or as part of a developmental disorder, Williams syndrome (WS). In recent studies we presented evidence suggesting that a translocation disrupting the elastin gene caused SVAS in one family while deletions involving the entire elastin locus caused WS. In this study, pulsed-field, PCR, and Southern analyses showed that a 100-kb deletion of the 3' end of the elastin gene cosegregated with the disease in another SVAS family. DNA sequence analysis localized the breakpoint between elastin exons 27 and 28, the same region disrupted by the SVAS-associated translocation. These data indicate that mutations in the elastin gene cause SVAS and suggest that elastin exons 28-36 may encode critical domains for vascular development.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8132745      PMCID: PMC294040          DOI: 10.1172/JCI117057

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  FAMILIAL SUPRAVALVULAR AORTIC STENOSIS.

Authors:  R EISENBERG; D YOUNG; B JACOBSON; A BOITO
Journal:  Am J Dis Child       Date:  1964-10

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

4.  Polymorphic DNA region adjacent to the 5' end of the human insulin gene.

Authors:  G I Bell; J H Karam; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

5.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

6.  Supravalvular aortic stenosis. Clinical and pathologic observations in six patients.

Authors:  W N O'Connor; J B Davis; R Geissler; C M Cottrill; J A Noonan; E P Todd
Journal:  Arch Pathol Lab Med       Date:  1985-02       Impact factor: 5.534

7.  Separation of yeast chromosome-sized DNAs by pulsed field gradient gel electrophoresis.

Authors:  D C Schwartz; C R Cantor
Journal:  Cell       Date:  1984-05       Impact factor: 41.582

8.  [The genetic aspects of Williams-Beuren syndrome and the isolated form of the supravalvular aortic stenosis. Investigation of 128 families (author's transl)].

Authors:  T Grimm; H Wesselhoeft
Journal:  Z Kardiol       Date:  1980-03

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils.

Authors:  L Y Sakai; D R Keene; E Engvall
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

View more
  43 in total

1.  Toward an understanding of the cause of mitral valve prolapse.

Authors:  J A Towbin
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

2.  Fluorescent in situ hybridisation (FISH) for hemizygous deletion at the elastin locus in patients with isolated supravalvular aortic stenosis.

Authors:  H Fryssira; R Palmer; K A Hallidie-Smith; J Taylor; D Donnai; W Reardon
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

3.  Decreased elastin in vessel walls puts the pressure on.

Authors:  Jeanine D'Armiento
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

4.  Impaired elastogenesis in Hurler disease: dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly.

Authors:  A Hinek; S E Wilson
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

5.  Bilateral semilunar valve dysplasia in a patient with inverted duplication 2p25-22.

Authors:  L K Kochilas; D N Abuelo; U Tantravahi
Journal:  Pediatr Cardiol       Date:  2007-08-04       Impact factor: 1.655

Review 6.  Vascular extracellular matrix and arterial mechanics.

Authors:  Jessica E Wagenseil; Robert P Mecham
Journal:  Physiol Rev       Date:  2009-07       Impact factor: 37.312

Review 7.  Neural phenotypes of common and rare genetic variants.

Authors:  Carrie E Bearden; David C Glahn; Agatha D Lee; Ming-Chang Chiang; Theo G M van Erp; Tyrone D Cannon; Allan L Reiss; Arthur W Toga; Paul M Thompson
Journal:  Biol Psychol       Date:  2008-02-23       Impact factor: 3.251

8.  Cardiovascular manifestations in 75 patients with Williams syndrome.

Authors:  M Eronen; M Peippo; A Hiippala; M Raatikka; M Arvio; R Johansson; M Kähkönen
Journal:  J Med Genet       Date:  2002-08       Impact factor: 6.318

9.  Developmental adaptation of the mouse cardiovascular system to elastin haploinsufficiency.

Authors:  Gilles Faury; Mylène Pezet; Russell H Knutsen; Walter A Boyle; Scott P Heximer; Sean E McLean; Robert K Minkes; Kendall J Blumer; Attila Kovacs; Daniel P Kelly; Dean Y Li; Barry Starcher; Robert P Mecham
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

10.  Genetics of congenital heart disease.

Authors:  Ashleigh A Richards; Vidu Garg
Journal:  Curr Cardiol Rev       Date:  2010-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.